![FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine](https://www.g2intelligence.com/wp-content/uploads/2023/04/56181_G2_stock_7-1080x675.jpg)
FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine
From - Diagnostic Testing & Emerging Technologies
In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first…